Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats

Brain Research

Volumn 1006, Issue 1, 2004, Pages 100-106

  Morris, Margaret J ^a   Pavia, Jillian M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Appetite; Endocrine and autonomic regulation; Hypothalamus; Neuroendocrine regulation: other; Neurotransmitter overflow; Type 1 diabetes

Indexed keywords

NEUROPEPTIDE Y; NORADRENALIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; DIABETES MELLITUS; HYPOTHALAMUS; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; EATING; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; NOREPINEPHRINE; POTASSIUM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 1642328682     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.02.002     Document Type: Article

References (34)

1. Abe M., Saito M., Ikeda H., Shimazu T. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res. 539:1991;223-227.
2. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smith A.D., Powell J.F., Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331:1985;172-175.
3. Barber M., Kasturi B.S., Austin M.E., Patel K.P., MohanKumar S.M.J., MohanKumar P.S. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res. 964:2003;128-135.
4. Bitar M.S., Koulu M., Linnoila M. Diabetes-induced changes in monoamine concentrations of rat hypothalamic nuclei. Brain Res. 409:1987;236-242.
5. Candy S.M., Szatkowski M.S. Chronic hyperglycaemia increases neuronal sensitivity to high potassium in hippocampal slices from streptozotocin-treated diabetic rats. Neurosci. Lett. 279:2000;105-108.
6. Chen C.C., Yang J.C. Effects of short and long-lasting diabetes mellitus on mouse brain monoamines. Brain Res. 552:1991;175-179.
7. Figlewicz D.P., Brot M.D., McCall A.L., Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 736:1996;54-60.
8. Gozali M., Pavia J.M., Morris M.J. Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats - in vitro and in vivo studies of transmitter release. Diabetologia. 45:2002;1332-1339.
9. Haass M., Cheng B., Richardt G., Lang R.E., Schömig A. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;71-78.
10. Hastings J., McClure-Sharp J., Morris M.J. In vitro studies of endogenous noradrenaline and NPY overflow during maturation and ageing. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;218-224.
11. Hastings J.A., McClure-Sharp J.M., Morris M.J. NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro. Brain Res. 890:2001;32-37.
12. Hastings J.A., Wiesner G., Lambert G., Morris M.J., Head G., Esler M. Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul. Pept. 103:2002;67-74.
13. Havel P.J., Hahn T.M., Sindelar D.K., Baskin D.G., Dallman M.F., Weigle D.S., Schwartz M.W. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes. 49:2000;244-252.
14. Hidaka S., Yoshimatsu H., Kondou S., Oka K., Tsuruta Y., Sakino H., Itateyama E., Noguchi H., Himeno K., Okamoto K., Teshima Y., Okeda T., Sakata T. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats. J. Neurochem. 77:2001;993-1000.
15. Karkanias G.B., Morales J.C., Etgen A.M. Effects of diabetes and estradiol on norepinephrine release in female rat hypothalamus, preoptic area and cortex. Neuroendocrinology. 68:1998;30-36.
16. Kim E.M., Grace M.K., Welch C.C., Billington C.J., Levine A.S. STZ-induced diabetes decreases and insulin normalises POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 276:1999;R1320-R1326.
17. Lackovic Z., Salkovic M., Kuci Z., Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54:1990;143-147.
18. Lambert P.D., Wilding J.P., Turton M.D., Ghatei M.A., Bloom S.R. Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure. Brain Res. 656:1994;135-140.
19. Lee J., Morris M.J. Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla. NeuroReport. 9:1998;1575-1580.
20. Marks J.L., Waite M.L. Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus. Diabetologia. 36:1993;497-502.
21. Morris M.J., Russell A.E., Kapoor V., Cain M.D., Elliott J.M., West M.J., Wing L.M.H., Chalmers J.P. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J. Auton. Nerv. Syst. 17:1986;143-149.
22. Muroya S., Yada T., Shioda S., Takigawa M. Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci. Lett. 264:1999;113-116.
23. Ohtani N., Ohta M., Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J. Neurochem. 69:1997;1622-1628.
24. Pavia J.M., Hastings J.A., Morris M.J. Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo. Brain Res. 690:1995;108-111.
25. Petrisic M.S., Augood S.J., Bicknell R.J. Monoamine transporter gene expression in the central nervous system in diabetes mellitus. J. Neurochem. 68:1997;2435-2441.
26. Sahu A., Sninsky C.A., Kalra P.S., Kalra S.P. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology. 126:1990;192-198.
27. Sahu A., Sninsky C.A., Phelps C.P., Dube M.G., Kalra P.S., Kalra S.P. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology. 131:1992;2979-2985.
28. Sahu A., Dube M.G., Phelps C.P., Sninsky C.A., Kalra P.S., Kalra S.P. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology. 136:1995;5718-5724.
29. Sahu A., Sninsky C.A., Kalra S.P. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res. 755:1997;339-342.
30. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. Rev. 4:1982;275-325.
31. Schwartz M.W., Sipols A.J., Marks J.L., Sanacora G., White J.D., Scheurink A., Kahn S.E., Baskin D.G., Woods S.C., Figlewicz D.P., Porte D. Jr. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:1992;3608-3616.
32. Schwartz M.W., Strack A.M., Dallman M.F. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin- releasing hormone gene expression in diabetes. Regul. Pept. 72:1997;105-112.
33. Shimizu H. Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat. Neurosci. Lett. 131:1991;225-227.
34. Stewart J.K., Campbell T.G., Gbadebo T.D., Narasimhachari N., Manning J.W. Cardiovascular responses and central catecholamines in streptozotocin- diabetic rats. Neurochem. Int. 24:1994;183-189.